Does a high omega-6 to omega-3 ratio favor inflammatory signaling?

The balance between dietary omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) dictates cellular lipid membrane composition and directly governs systemic inflammatory responses.

Enzymatic competition and inflammatory signaling

• Competitive substrate inhibition: Both omega-6 arachidonic acid (AA) and the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) compete for the same cyclooxygenase (COX) and lipoxygenase (LOX) enzymatic machinery.
• Upregulation of inflammatory mediators: An elevated substrate ratio allows abundant AA to outcompete EPA and DHA. This shift drives the production of classic omega-6-derived eicosanoids, such as prostaglandin E2 (PGE2), thromboxane A2 (TXA2), and leukotriene B4 (LTB4), which promote sustained inflammatory signaling, neutrophil recruitment, and tissue damage.

Suppression of active resolution pathways

• Impaired SPM synthesis: High relative levels of omega-6 substrates displace EPA and DHA from cellular membranes, severely limiting the production of specialized pro-resolving mediators (SPMs), including resolvins, protectins, and maresins.
• Loss of tissue homeostasis: SPMs are biologically required to actively orchestrate the resolution of inflammation by promoting macrophage efferocytosis (clearance of apoptotic cells and debris) and limiting neutrophil infiltration. Depleting these mediators prevents the timely termination of the inflammatory response, promoting chronic, low-grade tissue inflammation.

Bottom line

• A high omega-6 to omega-3 substrate ratio shifts metabolic pathways to favor the production of pro-inflammatory eicosanoids while simultaneously suppressing the synthesis of specialized pro-resolving mediators, ultimately preventing the active resolution of tissue inflammation.